Drug Guide

Generic Name

Glyburide

Brand Names Micronase, Diabeta, Glynase, Glyburide (micronized)

Classification

Therapeutic: Antidiabetic agent

Pharmacological: Sulfonylurea

FDA Approved Indications

Mechanism of Action

Glyburide stimulates insulin release from pancreatic beta cells by binding to sulfonylurea receptors, thereby increasing insulin secretion and decreasing blood glucose levels.

Dosage and Administration

Adult: Typically, 2.5 to 5 mg once daily before breakfast. Dose may be adjusted based on glycemic response, up to a maximum of 20 mg/day.

Pediatric: Not recommended for use in children.

Geriatric: Initial dose should be low, with careful monitoring due to increased risk of hypoglycemia.

Renal Impairment: Use with caution; may require dose adjustment or discontinuation due to accumulation.

Hepatic Impairment: Use with caution; careful monitoring recommended.

Pharmacokinetics

Absorption: Well absorbed from the gastrointestinal tract.

Distribution: Widely distributed; crosses the placenta.

Metabolism: Metabolized in the liver via oxidation and conjugation.

Excretion: Excreted primarily in feces and urine.

Half Life: 10 hours approximately.

Contraindications

Precautions

Adverse Reactions - Common

Adverse Reactions - Serious

Drug-Drug Interactions

Drug-Food Interactions

Drug-Herb Interactions

Nursing Implications

Assessment: Monitor blood glucose levels regularly. Assess for signs of hypoglycemia.

Diagnoses:

  • Risk for unstable blood glucose levels
  • Risk for hypoglycemia

Implementation: Administer with breakfast or the first main meal of the day. Educate patient on recognizing and managing hypoglycemia.

Evaluation: Evaluate blood glucose control regularly; adjust dose as needed.

Patient/Family Teaching

Special Considerations

Black Box Warnings:

Genetic Factors: Genetic polymorphisms may affect drug metabolism and response.

Lab Test Interference: May interfere with certain laboratory tests, including blood glucose measurements.

Overdose Management

Signs/Symptoms: Severe hypoglycemia—confusion, seizure, coma.

Treatment: Administer oral glucose if conscious; intramuscular or intravenous glucose for unconscious patients. Seek immediate medical care.

Storage and Handling

Storage: Store at room temperature away from moisture and heat.

Stability: Stable under recommended storage conditions.

This guide is for educational purposes only and is not intended for clinical use.